From the Department of Psychology (A.L.W.), Georgia State University, Atlanta; Department of Neurology (A.L.W.), University of Utah, Salt Lake City; Departments of Psychology (A.L.W., A.O., K.O.Y.) and Radiology (C.L., B.G.G.), Alberta Children's Hospital Research Institute, Hotchkiss Brain Institute, University of Calgary, Alberta, Canada; Computer Vision Group (A.O.), Sano Centre for Computational Medicine, Kraków 30-054, Poland; Department of Radiology (N.A.), University of Ottawa, Children's Hospital of Eastern Ontario Research Institute; Department of Psychology (M.H.B.), University of Montreal & CHU Sainte-Justine Hospital Research Center, Québec; Department of Biomedical Engineering (C.B.), University of Alberta, Edmonton; Division of Neurology (B.H.B.), Department of Pediatrics, University of British Columbia and BC Children's Hospital Research Institute, Vancouver; University of Alberta and Stollery Children's Hospital (W.C.), Edmonton; Department of Radiology (M.D.), Radio-oncology and Nuclear Medicine, Institute of Biomedical Engineering, University of Montreal; CHU Sainte-Justine Research Center, Québec; Department of Pediatrics (Q.D.), University of British Columbia, BC Children's Hospital Research Institute, Vancouver; CHU Sainte-Justine Research Center (S.D.), Department of Radiology, Radio-oncology and Nuclear Medicine, University of Montreal, Québec; Departments of Pediatrics and Emergency Medicine (S.B.F.), Cumming School of Medicine, University of Calgary, Alberta; Department of Pediatric Emergency Medicine (J.G.); CHU Sainte-Justine, Department of Pediatrics, University of Montréal, Québec; Children's Hospital of Eastern Ontario Research Institute (A.-A.L., R.Z.); Department of Cellular and Molecular Medicine (A.-A.L.) and Pediatrics and Emergency Medicine (R.Z.), University of Ottawa; and Department of Pediatrics and Emergency Medicine (R.Z.), University of Ottawa, Children's Hospital of Eastern Ontario Research Institute, Canada.
Neurology. 2023 Aug 15;101(7):e728-e739. doi: 10.1212/WNL.0000000000207508. Epub 2023 Jun 23.
This prospective, longitudinal cohort study examined trajectories of brain gray matter macrostructure after pediatric mild traumatic brain injury (mTBI).
Children aged 8-16.99 years with mTBI or mild orthopedic injury (OI) were recruited from 5 pediatric emergency departments. Reliable change between preinjury and 1 month postinjury symptom ratings was used to classify mTBI with or without persistent symptoms. Children completed postacute (2-33 days) and/or chronic (3 or 6 months) postinjury T1-weighted MRI, from which macrostructural metrics were derived using automated segmentation. Linear mixed-effects models were used, with multiple comparisons correction.
Groups ( = 623; 407 mTBI/216 OI; 59% male; age mean = 12.03, SD = 2.38 years) did not differ in total brain, white, or gray matter volumes or regional subcortical gray matter volumes. However, time postinjury, age at injury, and biological sex-moderated differences among symptom groups in cortical thickness of the angular gyrus, basal forebrain, calcarine cortex, gyrus rectus, medial and posterior orbital gyrus, and the subcallosal area all corrected < 0.05. Gray matter macrostructural metrics did not differ between groups postacutely. However, cortical thinning emerged chronically after mTBI relative to OI in the angular gyrus in older children ( [95% confidence interval] = -0.61 [-1.15 to -0.08]); and in the basal forebrain (-0.47 [-0.94 to -0.01]), subcallosal area (-0.55 [-1.01 to -0.08]), and the posterior orbital gyrus (-0.55 [-1.02 to -0.08]) in females. Cortical thinning was demonstrated for frontal and occipital regions 3 months postinjury in males with mTBI with persistent symptoms vs without persistent symptoms (-0.80 [-1.55 to -0.05] to -0.83 [-1.56 to -0.10]) and 6 months postinjury in females and younger children with mTBI with persistent symptoms relative to mTBI without persistent symptoms and OI (-1.42 [-2.29 to -0.45] to -0.91 [-1.81 to -0.01]).
These findings signal little diagnostic and prognostic utility of postacute gray matter macrostructure in pediatric mTBI. However, mTBI altered the typical course of cortical gray matter thinning up to 6 months postinjury, even after symptoms typically abate in most children. Collapsing across symptom status obscured the neurobiological heterogeneity of discrete clinical outcomes after pediatric mTBI. The results illustrate the need to examine neurobiology in relation to clinical outcomes and within a neurodevelopmental framework.
本前瞻性纵向队列研究旨在探讨儿童轻度创伤性脑损伤(mTBI)后脑灰质宏观结构的变化轨迹。
本研究招募了来自 5 家儿科急诊室的年龄在 8 至 16.99 岁之间的 mTBI 或轻度骨科损伤(OI)患儿。使用损伤前和损伤后 1 个月症状评分之间的可靠变化来分类有无持续性症状的 mTBI。患儿在亚急性期(2-33 天)和/或慢性期(3 或 6 个月)进行 T1 加权 MRI 检查,使用自动分割技术从 MRI 中提取宏观结构指标。使用线性混合效应模型进行分析,并进行了多次比较校正。
两组( = 623;407 例 mTBI/216 例 OI;59%为男性;年龄均值 = 12.03,标准差 = 2.38 岁)在总脑、白质或灰质体积或局部皮质下灰质体积方面没有差异。然而,在损伤后时间、损伤时年龄和生物性别方面,症状组之间的皮质厚度在角回、基底前脑、距状裂皮质、直回、内侧和后眶额皮质以及胼胝体下区存在差异,所有差异均校正后 < 0.05。mTBI 组和 OI 组在亚急性期的灰质宏观结构指标没有差异。然而,与 OI 相比,mTBI 后在大龄儿童的角回中出现慢性皮质变薄([95%置信区间] = -0.61 [-1.15 至 -0.08]);以及在基底前脑(-0.47 [-0.94 至 -0.01])、胼胝体下区(-0.55 [-1.01 至 -0.08])和后眶额皮质(-0.55 [-1.02 至 -0.08])中;在女性中。在 mTBI 后 3 个月,与无持续性症状的 mTBI 相比,有持续性症状的 mTBI 男性出现额叶和枕叶区域的皮质变薄(-0.80 [-1.55 至 -0.05]至 -0.83 [-1.56 至 -0.10]),在 mTBI 后 6 个月,与无持续性症状的 mTBI 和 OI 相比,有持续性症状的女性和年幼儿童出现皮质变薄(-1.42 [-2.29 至 -0.45]至 -0.91 [-1.81 至 -0.01])。
这些发现表明,在儿童 mTBI 中,亚急性期的灰质宏观结构对诊断和预后的应用价值不大。然而,mTBI 改变了皮质灰质变薄的典型过程,直到损伤后 6 个月,即使在大多数儿童的症状通常消退后也是如此。忽略症状状态掩盖了离散临床结局后的神经生物学异质性。研究结果表明,需要在神经发育框架内,根据临床结局和神经生物学来检查神经生物学。